Estudo laboratorial mostra escape imunológico significativo de variante Ômicron do SARS-CoV-2.
14 Dez, 2021 | 16:13hComunicado de imprensa: Vaccines and previous infection could offer some ‘stronger than basic’ protection to Omicron, early study suggests – Taylor & Francis Group